It is a business services private limited company based in New Delhi, Delhi, India, established in 2025.
2025 | New Delhi, Delhi, India | ActiveAxton Asia Drugs Private Limited, a active private limited company, was established on 29 December 2025 in New Delhi, Delhi, India. it holds CIN: U21001DL2025PTC460712. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Axton Asia Drugs Private Limited. Its leadership includes Sapna Srivastwa (Director), Anmol Saxena (Director). It is based at Plot No B/8 2Nd Floor, Sector 17, Dwarka, New Delhi, Delhi, 110078.
U21001DL2025PTC460712
460712
29 December 2025
₹2.50 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Axton Asia Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sapna Srivastwa | Director | 29 Dec 2025 | Current |
| Anmol Saxena | Director | 29 Dec 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Axton Asia Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Axton Asia Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Axton Asia Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axton Asia Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sapna Srivastwa was appointed as a Director was appointed as a Director on 29 Dec 2025 & has been associated with this company since 20 days . was completed.
Progress on Anmol Saxena was appointed as a Director was appointed as a Director on 29 Dec 2025 & has been associated with this company since 20 days . was documented.
Axton Asia Drugs Private Limited was registered on 29 Dec 2025 with Roc Delhi & aged 20 days as per MCA records. was recorded as a recent event.
The CIN of Axton Asia Drugs Private Limited is U21001DL2025PTC460712.
Axton Asia Drugs Private Limited is headquartered at Plot No B/8 2Nd Floor, Sector 17, Dwarka, New Delhi, Delhi, 110078.
Axton Asia Drugs Private Limited was incorporated on 29 December 2025.
The current directors of Axton Asia Drugs Private Limited are
Axton Asia Drugs Private Limited is unlisted.
The authorized capital of Axton Asia Drugs Private Limited is ₹2.50 Cr, and the paid-up capital is ₹1.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX